Grove Collaborative Holdings, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Grove Collaborative Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
364
384
322
259
203
174
Cost of revenue
188
195
167
122
94.1
80.4
Gross profit
176
189
155
137
109
93.3
Research and development
18.7
23.4
22.5
16.4
18.5
7.48
Selling, general and administrative
168
187
207
135
103
87.4
Operating income
-66.5
-129
-141
-35.3
-22.5
-11.3
Interest expense
5.61
5.2
9.69
16.1
12.8
1.23
Other non-operating income
-5.73
-6.99
53.3
-7.93
-4.84
-0.37
Pre-tax income
-72.2
-136
-87.7
-43.2
-27.4
-11.7
Income tax
0.04
0.05
0.05
0.04
0.04
0.03
Net income
-72.3
-136
-87.7
-43.2
-27.4
-11.7
EBITDA
-62.4
-124
-135
-29.4
-12.7
-9.64
EPS, basic
-67.23
-79.28
-4.85
-1.28
-0.76
-0.34
EPS, diluted
-67.23
-79.28
-4.85
-1.28
-0.76
-0.34
Shares, basic (weighted)
1.07
1.71
18.1
34.8
37
39
Shares, diluted (weighted)
1.07
1.71
18.1
34.8
37
39
Balance sheet
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
177
78.4
81.1
86.4
19.6
8.49
Receivables
0.44
3.11
Inventory
54.5
44.1
28.8
19.4
18.4
Other current assets
8.1
4.84
3.36
0.26
0.8
Total current assets
141
142
124
44.9
34.7
Property, plant and equipment
15.9
14.5
11.6
3.68
3.65
Lease right-of-use assets
21.2
12.4
9.61
12.5
9.54
Intangible assets
0.71
2.3
Other non-current assets
4.39
2.19
2.51
2.15
1.9
Total assets
182
174
151
65
53.1
Accounts payable
21.3
10.7
8.07
6.8
8.83
Accrued liabilities
20.7
31.4
16
11.5
9.48
Deferred revenue
11.3
10.9
7.15
6.34
5.03
Short-term debt
10.8
0.58
0
0
0.8
Total current liabilities
69.2
57.5
35
27.1
27.7
Long-term debt
56.2
60.6
71.7
7.5
6.7
Lease liabilities
20
16.2
14.4
12.9
10.1
Other non-current liabilities
5.41
0
Total liabilities
151
148
133
48.8
45.3
Total debt
66.9
61.2
71.7
7.5
6.7
Paid-in capital
33.9
604
629
640
643
Retained earnings
-490
-578
-621
-649
-660
Shareholders' equity
-340
-456
26.5
8.12
-8.55
-17
Total equity
-340
-456
26.5
8.12
-8.55
-17
Total liabilities and equity
182
174
151
65
53.1
Cash flow statement
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-72.3
-136
-87.7
-43.2
-27.4
-11.7
Depreciation and amortization
4.12
4.99
5.72
5.82
9.82
1.68
Stock-based compensation
7.76
14.6
45.7
15.5
12
4.28
Change in inventory
-18.6
-12.6
3.29
15
12.5
3.3
Change in payables
-16.3
-2.49
-10.5
-2.57
-1.27
-0.38
Cash from operations
-83.7
-127
-96.3
-7.99
-9.75
-6.95
Capital expenditures
-4.82
-5.77
-4.22
-2.99
-1.76
-1.17
Acquisitions
0
-2.85
Cash from investing
-4.82
-5.77
-4.22
-2.99
-1.62
-4
Debt issued
43.5
60
70.8
7.5
0
Debt repaid
-33.1
-21.9
-5.18
-0.58
Stock issued
0
0
4.92
0
Share buybacks
0
-0.3
-0.03
Cash from financing
228
34.7
118
9.86
-59.2
-1.56
Net change in cash
140
-98.1
17.6
-1.12
-70.6
-12.5
Free cash flow
-88.5
-133
-100
-11
-11.5
-8.12
Interest paid
3.89
4.47
10.1
12.1
9.42
0.6
Income taxes paid
0
0.05
0.07
0.04
0.05
0.03
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.07 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
53.6%
Gross profit / revenue.
Operating margin
-3.8%
Operating income / revenue.
EBITDA margin
-2.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-4.1%
Pre-tax income / revenue.
Net margin
-4.1%
Net income / revenue.
FCF margin
-0.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.3%
Cash from operations / revenue.
Return on assets (ROA)
-12.7%
Net income / average total assets.
R&D / revenue
4.1%
Research and development expense / revenue.
SG&A / revenue
49.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
2.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
1.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-14.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-18.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-13.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-14.7%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-15.5%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-11.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-18.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-32.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
5.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
29.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
105.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.26x
Current assets / current liabilities.
Quick ratio
0.33x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.31x
(Cash + short-term investments) / current liabilities.
Debt / assets
14.8%
Total debt / total assets.
Liabilities / assets
85.7%
Total liabilities / total assets.
Net debt
-$845.0K
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.16
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$3.92
Revenue / diluted weighted shares.
FCF per share
-$0.03
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.43
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.29x
Market cap / revenue.
EV/Sales
0.28x
Enterprise value / revenue.
FCF yield
-2.5%
Free cash flow / market cap.
Earnings yield
-14.2%
Net income / market cap (the inverse of P/E).
What was Grove Collaborative Holdings, Inc.'s revenue in fiscal 2025?
Grove Collaborative Holdings, Inc. reported revenue of $173.7M for fiscal 2025, 14.6% lower than the year before.
Was Grove Collaborative Holdings, Inc. profitable in fiscal 2025?
No. It reported a net loss of $11.7M.
How much free cash flow did Grove Collaborative Holdings, Inc. generate in fiscal 2025?
Cash from operations of $7.0M minus capital expenditures of $1.2M left free cash flow of -$8.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.